Unique ID issued by UMIN | UMIN000010994 |
---|---|
Receipt number | R000012855 |
Scientific Title | Double blinded randomised placebo controlled phase II trial of Shiunko Ointment local application twice a day for 4 weeks in Ethiopian patients with localized cutaneous Leishmaniasis. |
Date of disclosure of the study information | 2013/06/18 |
Last modified on | 2014/12/09 17:01:20 |
Double blinded randomised placebo controlled phase II trial of Shiunko Ointment local application twice a day for 4 weeks in Ethiopian patients with localized cutaneous Leishmaniasis.
Shiunko Project
Double blinded randomised placebo controlled phase II trial of Shiunko Ointment local application twice a day for 4 weeks in Ethiopian patients with localized cutaneous Leishmaniasis.
Shiunko Project
Africa |
Cutaneous Leishmaniasis.
Infectious disease | Adult |
Others
NO
To assess the efficacy of Shiunko ointment when applied on the lesion twice a day for 4 weeks in patients with localized Cutaneous Leishmaniasis.
Safety
Exploratory
Explanatory
Phase II
Cure rate
Safety
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Treatment
Medicine |
Shiunko ointment
Placebo
18 | years-old | <= |
65 | years-old | >= |
Male and Female
1.Presence of new , active lesion , localized solid cutaneous leishmaniasis lesion on exposed sites like face, extremities, diagnosed by staining techniques on lesion aspirate or smear from scraping on the index lesion and PCR, with no previous treatment in the past 6 months
2. Age: 18 - 65 years
3. Has an identifiable address and expects to remain in the area for the duration of the study.
1. Patients with multiple lesions,mucocutaneousand/or diffused Cutaneous Leishmaniasis
2. Abnormal biochemical and/or haematological laboratory values and considered clinically relevant.
3. Any condition which to comply with the study procedures.
4. Known hypersensitivity to any of the trial product components.
5. Pregnancy as confirmed by urine HCG in female of reproductive age
40
1st name | |
Middle name | |
Last name | Oumer Ali |
Armauer Hansen Research Institute ALERT
Clinical Trial Center
P.O. Box 1005.Addis Ababa, Ethiopia
251-113211-334
oumer2003@gmail.com
1st name | |
Middle name | |
Last name | Juntra Karbwang Laothavorn |
Nagasaki University
Clinical Product Development Department
1-12-4 Sakamoto Nagasaki Japan
095-819-7558
kawbwangj@nagasaki-u.ac.jp
Nagasaki University
Ministry of Education
Japan
NO
Nagasaki University(長崎県)
2013 | Year | 06 | Month | 18 | Day |
Unpublished
Forty patients with cutaneous leishmaniasis (CL) (62.5% male, aged 18-62 years) were recruited and then randomized to receive either placebo or Shiuko treatment. In the first four weeks of treatment period, the rate of lesion reduction was significantly faster in the Shiunko compared with placebo. Clinical efficacy of Shiunko vs. placebo based on intention-to-treat and per-protocol analysis were similar with regard to proportions of patients with cure.
No significant change in laboratory parameters in both groups was found. The frequencies of adverse events were not different between both groups.
Completed
2013 | Year | 02 | Month | 12 | Day |
2013 | Year | 04 | Month | 10 | Day |
2014 | Year | 01 | Month | 30 | Day |
2014 | Year | 02 | Month | 13 | Day |
2014 | Year | 03 | Month | 30 | Day |
2014 | Year | 11 | Month | 04 | Day |
2013 | Year | 06 | Month | 18 | Day |
2014 | Year | 12 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012855